Status:

COMPLETED

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Lead Sponsor:

Fidec Corporation

Collaborating Sponsors:

Bill and Melinda Gates Foundation

Conditions:

Poliomyelitis

Eligibility:

All Genders

5-7 years

Phase:

PHASE3

Brief Summary

The study will assess and compare the immune response to full-dose inactivated polio vaccines (IPV) via intramuscular (IM) administration and of the fractional dose of inactivated poliovirus vaccine (...

Detailed Description

This study prioritizes comparisons involving two-dose regimens recently recommended by the World Health Organization (WHO) Strategic Advisory Group of Experts on immunization (SAGE) and Pan American H...

Eligibility Criteria

Inclusion

  • Infants of 6 weeks of age (-7 to + 7 days) on date of enrollment.
  • Healthy, as assessed from medical history and physical examination by a study physician,
  • Written informed consent obtained from parents or legal representatives who have been properly informed about the study and are able to comply with planned study procedures.

Exclusion

  • Vaccinated with any poliovirus vaccine prior to inclusion,
  • A household contact with OPV vaccination history in the past 4 weeks,
  • HIV infection or pharmacologic immunosuppression,
  • Known allergy to any component of the study vaccines (phenoxyethanol, formaldehyde),
  • Uncontrolled coagulopathy or blood disorder contraindicating intramuscular and intradermal injections,
  • Acute severe febrile illness on day of vaccination deemed by the Investigator(s) to be a contraindication for vaccination,
  • Not suitable for inclusion or is unlikely to comply with the protocol in the opinion of the investigator(s).

Key Trial Info

Start Date :

October 23 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 13 2018

Estimated Enrollment :

773 Patients enrolled

Trial Details

Trial ID

NCT03239496

Start Date

October 23 2017

End Date

November 13 2018

Last Update

July 21 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hospital Universitario Nuestra Señora de la Alta Gracia

Santo Domingo, Dominican Republic

2

Cevaxin Vaccination Center

David, Panama

3

Cevaxin Vaccination Center

La Chorrera, Panama

4

Cevaxin Vaccination Center

Panama City, Panama